Loading clinical trials...
Loading clinical trials...
Examination of the Multiple Genetic and Molecular Targets as Therapeutic Options for Patients With Ependymoma Treated by the Phase II Children's Oncology Group Study ACNS0121
Conditions
Interventions
laboratory biomarker analysis
Locations
1
United States
Children's Oncology Group
Monrovia, California, United States
Start Date
March 1, 2012
Primary Completion Date
April 1, 2013
Completion Date
April 1, 2013
Last Updated
May 18, 2016
NCT02194452
NCT00326664
Lead Sponsor
Children's Oncology Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions